GlassScriptPhysician profile
Marc J Lamb
NPI 1447273180
$2,793.18
in general payments reported to CMS, 2019-2025
10 companies · $90.99 in 2025
The $90.99 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $2,320 · 2021: $57.30 · 2022: $13.98 · 2023: $38.78 · 2024: $120 · 2025: $90.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $249.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes USA Products LLC | $2,279.19 | 2020 | |
| Endo Pharmaceuticals INC. | $201.46 | 2019-2023 | Xiaflex |
| Depuy Synthes Sales INC. | $98.76 | 2023-2025 | Na, Unium |
| Axogen | $63.93 | 2019-2020 | |
| Orthofix Medical, INC. | $43.75 | 2024 | Physio-Stim |
| Eclipse Technology Solutions INC. | $30.91 | 2025 | |
| Stryker Corporation | $30.20 | 2025 | Pangea |
| Spinal Elements, INC. | $17.92 | 2024 | |
| Endo USA, INC. | $14.31 | 2024 | Xiaflex |
| Horizon Therapeutics Plc | $12.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Lamb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.